Chronic HBV was associated with increased risk for adverse COVID-19 outcomes, but the risk was lower among coinfected patients vaccinated against COVID-19.

ShareHepatitis B remains one of the most pressing yet overlooked public health challenges worldwide. Affecting over 296 million people, this viral infection of the liver has long been labeled a ...

Somchai, a Thai native, was 21 years old and faced a double threat to his long-term health and wellbeing. He was living with ...

An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.

The following is a summary of “Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral ...

Warminster-based Arbutus Biopharma laid off over half of its workforce and is leaving its headquarters to conserve cash while ...

Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...

Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

Xie Qing, director of infectious diseases department at Ruijin Hospital, which is affiliated with Shanghai Jiao Tong ...

Hepatitis B virus (HBV) infection is associated with liver diseases, including chronic hepatitis, which notably increases the risk of cirrhosis and hepatocellular carcinoma (HCC) development. Although ...

Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to ...